Woodmont Investment Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.3M Buy
173,179
+740
+0.4% +$86.6K 1.21% 22
2026
Q1
$20.7M Buy
172,439
+1,932
+1% +$223K 1.28% 20
2025
Q4
$17.9M Buy
170,507
+3,189
+2% +$299K 1.13% 23
2025
Q3
$14M Sell
167,318
-9,567
-5% -$788K 0.93% 28
2025
Q2
$14M Buy
176,885
+6,486
+4% +$516K 0.92% 28
2025
Q1
$15.3M Buy
170,399
+9,444
+6% +$882K 1.1% 23
2024
Q4
$16M Sell
160,955
-4,338
-3% -$447K 1.18% 19
2024
Q3
$18.8M Buy
165,293
+2,931
+2% +$348K 1.41% 17
2024
Q2
$20.1M Buy
162,362
+2,136
+1% +$275K 1.64% 14
2024
Q1
$21.1M Buy
160,226
+1,595
+1% +$197K 1.78% 13
2023
Q4
$17.3M Buy
158,631
+1,969
+1% +$204K 1.62% 12
2023
Q3
$16.1M Sell
156,662
-510
-0.3% -$55K 1.71% 11
2023
Q2
$18.1M Sell
157,172
-5,515
-3% -$626K 1.88% 7
2023
Q1
$17.3M Buy
162,687
+1,370
+0.8% +$148K 1.84% 8
2022
Q4
$17.9M Sell
161,317
-2,039
-1% -$208K 2.03% 8
2022
Q3
$14.1M Buy
163,356
+4,098
+3% +$366K 1.76% 8
2022
Q2
$14.5M Sell
159,258
-831
-0.5% -$73.7K 1.79% 8
2022
Q1
$13.1M Buy
160,089
+5,623
+4% +$443K 1.52% 11
2021
Q4
$11.8M Buy
154,466
+11,014
+8% +$877K 1.51% 11
2021
Q3
$10.8M Buy
143,452
+22,416
+19% +$1.7M 1.57% 11
2021
Q2
$9.41M Buy
121,036
+17,255
+17% +$1.28M 1.48% 12
2021
Q1
$7.63M Buy
103,781
+10,912
+12% +$805K 1.3% 23
2020
Q4
$7.25M Buy
92,869
+14,283
+18% +$1.09M 1.35% 18
2020
Q3
$6.22M Buy
78,586
+15,276
+24% +$1.2M 1.33% 18
2020
Q2
$4.67M Buy
63,310
+2,096
+3% +$158K 1.12% 20
2020
Q1
$4.49M Buy
61,214
+4,998
+9% +$393K 1.24% 18
2019
Q4
$4.88M Buy
56,216
+2,348
+4% +$193K 1.11% 26
2019
Q3
$4.33M Sell
53,868
-1,184
-2% -$94.9K 1.06% 27
2019
Q2
$4.41M Buy
55,052
+1,201
+2% +$92K 1.09% 30
2019
Q1
$4.27M Sell
53,851
-1,390
-3% -$104K 1.11% 28
2018
Q4
$4.03M Buy
55,241
+2,725
+5% +$192K 1.13% 26
2018
Q3
$3.56M Sell
52,516
-1,137
-2% -$72.4K 0.97% 32
2018
Q2
$3.11M Buy
53,653
+319
+0.6% +$18K 0.86% 35
2018
Q1
$2.77M Sell
53,334
-3,642
-6% -$197K 0.77% 41
2017
Q4
$3.06M Buy
56,976
+10,692
+23% +$593K 0.79% 40
2017
Q3
$2.83M Sell
46,284
-13
-0% -$788 0.77% 41
2017
Q2
$2.83M Buy
46,297
+890
+2% +$54.2K 0.8% 40
2017
Q1
$2.55M Hold
45,407
0.74% 43
2016
Q4
$2.55M Buy
45,407
+3,256
+8% +$191K 0.73% 42
2016
Q3
$2.51M Sell
42,151
-707
-2% -$41.3K 0.72% 42
2016
Q2
$2.36M Sell
42,858
-1,528
-3% -$81.3K 0.7% 47
2016
Q1
$2.24M Sell
44,386
-1,074
-2% -$52.6K 0.68% 44
2015
Q4
$2.29M Buy
45,460
+11,056
+32% +$557K 0.67% 43
2015
Q3
$1.62M Buy
34,404
+15,432
+81% +$820K 0.49% 63
2015
Q2
$1.03M Sell
18,972
-1,100
-5% -$61.7K 0.3% 95
2015
Q1
$1.1M Sell
20,072
-158
-0.8% -$8.95K 0.34% 85
2014
Q4
$1.1M Sell
20,230
-1,051
-5% -$58.6K 0.34% 88
2014
Q3
$1.2M Buy
21,281
+262
+1% +$14.7K 0.35% 90
2014
Q2
$1.16M Sell
21,019
-104
-0.5% -$5.67K 0.33% 95
2014
Q1
$1.14M Buy
21,123
+209
+1% +$10.8K 0.33% 93
2013
Q4
$999K Sell
20,914
-503
-2% -$23K 0.3% 98
2013
Q3
$973K Buy
21,417
+1,247
+6% +$56.9K 0.35% 85
2013
Q2
$894K Buy
+20,170
New +$901K 0.3% 97

Other funds holding MRK

Woodmont Investment Counsel's MRK Position: Q2 2026 in Review

Woodmont Investment Counsel increased its Merck (MRK) stake by 0.43% in Q2 2026, buying an estimated $86.6K and bringing the position to 173,179 shares worth $22.3M. The position accounts for 1.21% of the portfolio, ranked #22.

Woodmont Investment Counsel first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 2,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Woodmont Investment Counsel held 173,179 shares of Merck worth $22.3M as of Q2 2026.
  • Woodmont Investment Counsel bought 740 Merck shares in Q2 2026, an estimated $86.6K.
  • Merck made up 1.21% of Woodmont Investment Counsel's portfolio in Q2 2026, its #22 holding.
  • Woodmont Investment Counsel first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • 2,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Woodmont Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.